Blood Group Typing Market Outlook Signals Expansion To $6.46 Billion Through 2030

Understanding the future outlook of the blood group typing market reveals promising growth driven by technological advancements and increasing demand for efficient diagnostic solutions. This report delves into the market size forecast, key players, emerging trends, and various segments shaping the landscape of blood group typing worldwide.

Projected Market Size and Growth of the Blood Group Typing Market
The blood group typing market is anticipated to expand significantly over the coming years, reaching a value of $6.46 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 13.2%. Factors contributing to this rapid expansion include the rising adoption of molecular typing techniques, increasing demand for rapid compatibility testing, the broadening use of automated laboratory workflows, growing investments in transfusion safety, and continuous technological progress in blood group diagnostics. Key trends expected to influence this market involve greater integration of automated blood typing systems, increasing reliance on high-throughput testing platforms, wider use of molecular blood group typing methods, enhanced development of reagent and kit solutions, and a stronger emphasis on transfusion safety protocols.

Download a free sample of the blood group typing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4092&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Organizations Driving Innovation in the Blood Group Typing Industry
Several prominent companies dominate the blood group typing market, including Grifols S.A., Bio-Rad Laboratories Inc., Immucor Inc., Ortho-Clinical Diagnostics Inc., Quotient Limited, AXO Science SAS, Agena Bioscience Inc., Merck KGaA, Beckman Coulter Inc., DIAGAST SAS, Thermo Fisher Scientific Inc., One Lambda Inc., Tulip Diagnostics (P) Ltd., Guangzhou Wondfo Biotech Co. Ltd., DiaSorin S.p.A., Grifols Diagnostic Solutions Inc., Hemo bioscience Inc., Medion Diagnostics GmbH, ZenTech S.A., BioMedomics Inc., and Lifespan Diagnostics LLC.

Highlighting a major market development, in March 2023, Spain-based Werfen, S.A., which specializes in blood group typing, hemostasis, and transfusion, acquired Immucor Inc. for roughly US$2 billion. This acquisition strengthened Werfen's position as a key player in specialized diagnostics by expanding its portfolio to include transfusion and transplant products alongside its existing Hemostasis, Acute Care, and Autoimmunity lines. Immucor, headquartered in the United States, is well known for its blood group typing technologies.

View the full blood group typing market report:
https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Innovations and Technological Advances in Blood Group Typing
Companies active in the blood group typing market are heavily investing in cutting-edge technologies to improve testing precision and efficiency. One of the most notable advancements is the integration of next-generation sequencing (NGS), which allows for comprehensive and detailed analysis of genetic variations in blood group antigens. This technique enhances the accuracy of blood typing and supports more reliable compatibility assessments. For example, in April 2023, Metropolis Healthcare Limited from India introduced the NextGen HLA Typing Test, utilizing NGS technology to provide enhanced accuracy in human leukocyte antigen (HLA) typing, which is vital for successful organ transplantation by better matching donors and recipients.

Blood Group Typing Market Segmentation Overview
The blood group typing market is categorized into several key segments:
1) By Test Type: Antibody Screening, Cross-Matching Tests, ABO Tests, Antigen Typing, HLA Typing
2) By Product: Instruments, Reagents and Kits
3) By Techniques: Serology Tests, Molecular Tests
4) By End User: Hospital-Based Laboratories, Independent Laboratories, and Blood Banks

Further subdivisions include:
- Antibody Screening tests such as Indirect Coombs Test and Enzyme-Linked Immunosorbent Assay (ELISA)
- Cross-Matching Tests, including Major Crossmatch, Minor Crossmatch, and Electronic Crossmatch
- ABO Tests divided into Forward Typing and Reverse Typing
- Antigen Typing covering Rh Factor Typing, Kell Typing, and other blood group antigen typings
- HLA Typing performed through Serological Methods and Molecular Methods (such as PCR-based techniques)

This detailed segmentation helps to provide a comprehensive understanding of the components and applications driving the blood group typing market forward.

Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.